Dr. Barbara Taylor, Infectious Diseases, and her research team at UT Health San Antonio are featured in this San Antonio Business Journal story about Novavax sharing its findings from a Phase 3 clinical trial involving UT Health San Antonio and University Health.

Read the story.

The post San Antonio Business Journal: Alamo City research contributes to potential new COVID vaccine appeared first on UT Health San Antonio.